Introduction: Who Should Seek Diagnostic Testing
If you notice any changes in your skin—whether it’s a new spot, a mole that looks different from others, or an existing mark that has started to evolve—it is important to seek medical advice. Stage III melanoma means the cancer has already moved beyond the skin surface to nearby lymph nodes, lymph vessels, or surrounding skin tissue, so early diagnosis is essential for planning the next steps in care.[1]
Anyone who has already been diagnosed with melanoma should remain especially vigilant, as the disease can progress or spread even after initial treatment. People with fair skin, a history of sunburns, multiple moles (especially those that look unusual or atypical—meaning they differ in size, shape, or color from normal moles), or a family history of melanoma are at higher risk and should consider regular skin checks.[3][6]
It is also advisable to undergo diagnostic evaluation if you feel swollen lumps under your skin, particularly in areas close to a previous melanoma site, such as the neck, armpits, or groin. These lumps might indicate that melanoma cells have reached the lymph nodes. Even if you haven’t noticed obvious symptoms, regular screening appointments with a dermatologist can catch changes early, when they are easier to address.[2]
Diagnostic Methods to Identify Superficial Spreading Melanoma Stage III
Visual Skin Examination
The diagnostic journey often begins with a thorough skin examination by a healthcare professional, typically a dermatologist. During this exam, the doctor will look at all areas of your skin, not just the spot you’re concerned about. They use a simple memory tool called the ABCDE rule to help identify suspicious lesions.[6][16]
The ABCDE rule stands for: Asymmetry (one half of the lesion doesn’t match the other), Border irregularity (edges are uneven or blurred), Color variation (multiple shades of brown, black, red, or white within the same spot), Diameter (larger than 6 millimeters, roughly the size of a pencil eraser), and Evolving (the lesion is changing over time). Superficial spreading melanoma often shows all or several of these features.[3][15]
Another helpful sign is the “ugly duckling” rule. If one mole on your body looks noticeably different from all the others—like a duckling that doesn’t match its siblings—it should be examined closely. Visual inspection is non-invasive and painless, but it is only the first step. To confirm a diagnosis, tissue must be examined under a microscope.[16]
Excision Biopsy
When a suspicious area is identified, the doctor will typically recommend removing it entirely for examination. This procedure is called an excision biopsy. A small surgical cut is made to take out the abnormal area along with a thin margin of surrounding healthy skin. The tissue is then sent to a laboratory where a specialist doctor, known as a pathologist, examines it under a microscope.[2][14]
The pathologist checks whether melanoma cells are present and, if they are, measures how deeply the cancer has grown into the layers of skin. This measurement, called the Breslow thickness, helps determine the stage of the melanoma. The pathologist also looks for signs of ulceration, which means the top layer of the melanoma appears broken when viewed under the microscope. The presence or absence of ulceration is important for understanding how aggressive the melanoma may be.[1][9]
Excision biopsy is considered the gold standard for diagnosing melanoma because it provides the most complete information. It allows doctors to see the full structure of the tumor and make accurate decisions about staging and treatment.[14]
Sentinel Lymph Node Biopsy
Once melanoma is confirmed in the skin, the next critical question is whether cancer cells have spread to nearby lymph nodes. Lymph nodes are small, bean-shaped structures that are part of the body’s immune system. They filter fluid and trap harmful substances, including cancer cells. In stage III melanoma, cancer has reached these nodes or the areas between the original tumor and the lymph nodes.[1][2]
To check for cancer spread, doctors often perform a sentinel lymph node biopsy (SLNB). The sentinel lymph node is the first node to which cancer cells are likely to travel from the primary tumor. During this procedure, a small amount of radioactive material or blue dye is injected near the melanoma site. This substance travels through the lymphatic vessels to the first lymph node in the chain. The surgeon then removes this node and sends it to the lab for examination.[2][18]
If cancer cells are found in the sentinel node, it confirms that the melanoma has spread and helps classify it as stage III. The number of affected lymph nodes and whether the cancer can only be seen under a microscope or is visible to the naked eye both influence the sub-stage classification (IIIA, IIIB, IIIC, or IIID).[1][9]
The SLNB is usually performed at the same time as a surgery called wide local excision, where a larger area of skin around the melanoma is removed to ensure clear margins. This combined approach helps doctors gather all the information needed to determine the exact stage and plan further treatment.[2]
Ultrasound Examination and Fine Needle Biopsy
If a doctor can feel that your lymph nodes near the melanoma are swollen or enlarged during a physical exam, they may recommend an ultrasound scan instead of a sentinel lymph node biopsy. An ultrasound uses sound waves to create images of the inside of your body. It is a painless, non-invasive test that can show whether lymph nodes look abnormal in size or shape.[2][18]
If the ultrasound reveals suspicious nodes, the doctor may take a small tissue sample from the node using a thin needle. This is called a fine needle biopsy or needle aspiration. The sample is examined under a microscope to check for melanoma cells. This approach provides a less invasive way to confirm whether cancer has spread to the lymph nodes when they are already visibly or physically enlarged.[2]
Imaging Tests
Once stage III melanoma is diagnosed, doctors may use imaging tests to get a clearer picture of how far the cancer has spread and to check whether any organs have been affected. While stage III means the cancer is still considered regional (not distant), imaging helps rule out spread to other parts of the body and supports treatment planning.[2]
Common imaging tests include computed tomography (CT) scans, which use X-rays to create detailed cross-sectional images of the body, and positron emission tomography (PET) scans, which use a small amount of radioactive sugar to highlight areas where cancer cells are more active. These scans can detect cancer deposits that are too small to feel or see during a physical exam.[14]
Imaging is not always necessary for every patient, and your doctor will decide based on your individual situation, including the thickness of the melanoma, the presence of ulceration, and the number of affected lymph nodes.[14]
Understanding the Pathology Report
After all biopsies and tests are completed, you will receive a detailed pathology report. This document contains crucial information about your melanoma, including its thickness, whether ulceration is present, how many lymph nodes are involved, and whether cancer cells were found in the skin between the original tumor and the nearest lymph node. These deposits are called satellite metastases (within 2 cm of the melanoma) or in-transit metastases (further than 2 cm but not yet reaching a lymph node).[2][18]
The pathology report helps your medical team assign a precise sub-stage within stage III (IIIA, IIIB, IIIC, or IIID) and guide decisions about surgery, additional treatments, and follow-up care. Understanding this report can feel overwhelming, but your healthcare team will explain what each part means and how it applies to your situation.[1]
Diagnostics for Clinical Trial Qualification
Clinical trials are research studies that test new treatments or combinations of treatments to find better ways to manage melanoma. If you are considering participating in a clinical trial, you will need to undergo specific diagnostic tests to determine whether you meet the eligibility criteria. These criteria are designed to ensure the trial can answer its research questions safely and effectively.[2]
Most clinical trials for stage III melanoma require confirmation of the stage through the same diagnostic methods described earlier: excision biopsy, sentinel lymph node biopsy, and imaging tests. Detailed pathology results, including tumor thickness, ulceration status, and the exact number and location of involved lymph nodes, are often necessary to qualify.[1][9]
Some trials also require biomarker testing, which looks for specific genetic mutations or proteins in the cancer cells. For example, many superficial spreading melanomas have a mutation called BRAF V600E. Testing for this mutation involves analyzing a sample of tumor tissue. If the mutation is present, you may be eligible for trials testing targeted therapies designed to block the effects of this abnormal protein.[3][15]
Blood tests are commonly required before joining a trial. These tests check your general health, including liver and kidney function, blood cell counts, and markers of inflammation or infection. Baseline imaging scans, such as CT or PET scans, are often repeated at the start of a trial to document the extent of disease and allow researchers to measure how well the treatment is working over time.[14]
In some cases, a fresh biopsy of tumor tissue may be needed for research purposes, even if previous biopsies have already confirmed the diagnosis. This allows scientists to study the molecular characteristics of your melanoma in more detail and may help improve treatments for future patients.[14]
Participating in a clinical trial can offer access to cutting-edge treatments that are not yet widely available. Your doctor can help you understand which trials might be suitable for you and what additional tests would be required for enrollment.[2]
